TrialFrontiers in immunology2021

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.

Christian Martin Seitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.